FAIR VALUE (Tables)
|
9 Months Ended |
Jun. 30, 2025 |
Fair Value Disclosures [Abstract] |
|
Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis |
The following tables present assets and liabilities measured at fair value on a recurring basis. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | Level 1 | | Level 2 | | Level 3 | | Netting adjustments (1) | | Balance as of June 30, 2025 | Assets at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | Municipal and provincial obligations | | $ | 10 | | | $ | 298 | | | $ | — | | | $ | — | | | $ | 308 | | Corporate obligations | | 15 | | | 628 | | | — | | | — | | | 643 | | Government and agency obligations | | 28 | | | 119 | | | — | | | — | | | 147 | | Agency mortgage-backed securities (“MBS”), collateralized mortgage obligations (“CMOs”) and asset-backed securities (“ABS”) | | — | | | 171 | | | — | | | — | | | 171 | | Non-agency CMOs and ABS | | — | | | 39 | | | — | | | — | | | 39 | | Total debt securities | | 53 | | | 1,255 | | | — | | | — | | | 1,308 | | Equity securities | | 8 | | | 5 | | | — | | | — | | | 13 | | Brokered certificates of deposit | | — | | | 26 | | | — | | | — | | | 26 | | Other | | — | | | — | | | 2 | | | — | | | 2 | | Total trading assets | | 61 | | | 1,286 | | | 2 | | | — | | | 1,349 | | Available-for-sale securities (2) | | 432 | | | 6,733 | | | — | | | — | | | 7,165 | | Derivative assets: | | | | | | | | | | | Interest rate | | 11 | | | 322 | | | — | | | (261) | | | 72 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other | | — | | | — | | | 1 | | | — | | | 1 | | Total derivative assets | | 11 | | | 322 | | | 1 | | | (261) | | | 73 | | | | | | | | | | | | | All other investments: | | | | | | | | | | | Government and agency obligations (3) | | 91 | | | — | | | — | | | — | | | 91 | | Other | | 106 | | | 1 | | | 7 | | | — | | | 114 | | Total all other investments | | 197 | | | 1 | | | 7 | | | — | | | 205 | | Other assets - client-owned fractional shares | | 155 | | | — | | | — | | | — | | | 155 | | Subtotal | | 856 | | | 8,342 | | | 10 | | | (261) | | | 8,947 | | Other investments - private equity - measured at net asset value (“NAV”) | | | | | | | | | | 110 | | Total assets at fair value on a recurring basis | | $ | 856 | | | $ | 8,342 | | | $ | 10 | | | $ | (261) | | | $ | 9,057 | | | | | | | | | | | | | Liabilities at fair value on a recurring basis: | | | | | | | | | | | Trading liabilities: | | | | | | | | | | | Municipal and provincial obligations | | $ | 2 | | | $ | — | | | $ | — | | | $ | — | | | $ | 2 | | Corporate obligations | | — | | | 616 | | | — | | | — | | | 616 | | Government and agency obligations | | 153 | | | — | | | — | | | — | | | 153 | | Agency MBS and CMOs | | — | | | 25 | | | — | | | — | | | 25 | | | | | | | | | | | | | Total debt securities | | 155 | | | 641 | | | — | | | — | | | 796 | | Equity securities | | 124 | | | — | | | — | | | — | | | 124 | | | | | | | | | | | | | Total trading liabilities | | 279 | | | 641 | | | — | | | — | | | 920 | | Derivative liabilities: | | | | | | | | | | | Interest rate | | 11 | | | 327 | | | — | | | (131) | | | 207 | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 3 | | | — | | | — | | | 3 | | | | | | | | | | | | | Total derivative liabilities | | 11 | | | 330 | | | — | | | (131) | | | 210 | | Other payables - repurchase liabilities related to client-owned fractional shares | | 155 | | | — | | | — | | | — | | | 155 | | Total liabilities at fair value on a recurring basis | | $ | 445 | | | $ | 971 | | | $ | — | | | $ | (131) | | | $ | 1,285 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | Level 1 | | Level 2 | | Level 3 | | Netting adjustments (1) | | Balance as of September 30, 2024 | Assets at fair value on a recurring basis: | | | | | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | Municipal and provincial obligations | | $ | 2 | | | $ | 304 | | | $ | — | | | $ | — | | | $ | 306 | | Corporate obligations | | 12 | | | 630 | | | — | | | — | | | 642 | | Government and agency obligations | | 49 | | | 144 | | | — | | | — | | | 193 | | Agency MBS, CMOs, and ABS | | — | | | 205 | | | — | | | — | | | 205 | | Non-agency CMOs and ABS | | — | | | 95 | | | — | | | — | | | 95 | | Total debt securities | | 63 | | | 1,378 | | | — | | | — | | | 1,441 | | Equity securities | | 14 | | | 2 | | | — | | | — | | | 16 | | Brokered certificates of deposit | | — | | | 20 | | | — | | | — | | | 20 | | Other | | — | | | — | | | 3 | | | — | | | 3 | | Total trading assets | | 77 | | | 1,400 | | | 3 | | | — | | | 1,480 | | Available-for-sale securities (2) | | 704 | | | 7,556 | | | — | | | — | | | 8,260 | | Derivative assets: | | | | | | | | | | | Interest rate | | 3 | | | 335 | | | — | | | (246) | | | 92 | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 7 | | | — | | | — | | | 7 | | Other | | — | | | — | | | 4 | | | — | | | 4 | | Total derivative assets | | 3 | | | 342 | | | 4 | | | (246) | | | 103 | | | | | | | | | | | | | All other investments: | | | | | | | | | | | Government and agency obligations (3) | | 91 | | | — | | | — | | | — | | | 91 | | Other | | 101 | | | 1 | | | 7 | | | — | | | 109 | | Total all other investments | | 192 | | | 1 | | | 7 | | | — | | | 200 | | Other assets - client-owned fractional shares | | 133 | | | — | | | — | | | — | | | 133 | | Subtotal | | 1,109 | | | 9,299 | | | 14 | | | (246) | | | 10,176 | | Other investments - private equity - measured at NAV | | | | | | | | | | 102 | | Total assets at fair value on a recurring basis | | $ | 1,109 | | | $ | 9,299 | | | $ | 14 | | | $ | (246) | | | $ | 10,278 | | | | | | | | | | | | | Liabilities at fair value on a recurring basis: | | | | | | | | | | | Trading liabilities: | | | | | | | | | | | Municipal and provincial obligations | | $ | 5 | | | $ | — | | | $ | — | | | $ | — | | | $ | 5 | | Corporate obligations | | — | | | 598 | | | — | | | — | | | 598 | | Government and agency obligations | | 243 | | | 6 | | | — | | | — | | | 249 | | Agency MBS and CMOs | | — | | | 26 | | | — | | | — | | | 26 | | Total debt securities | | 248 | | | 630 | | | — | | | — | | | 878 | | Equity securities | | 97 | | | 1 | | | — | | | — | | | 98 | | | | | | | | | | | | | Total trading liabilities | | 345 | | | 631 | | | — | | | — | | | 976 | | Derivative liabilities: | | | | | | | | | | | Interest rate | | 3 | | | 343 | | | — | | | (123) | | | 223 | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange | | — | | | 1 | | | — | | | — | | | 1 | | | | | | | | | | | | | Total derivative liabilities | | 3 | | | 344 | | | — | | | (123) | | | 224 | | Other payables - repurchase liabilities related to client-owned fractional shares | | 133 | | | — | | | — | | | — | | | 133 | | Total liabilities at fair value on a recurring basis | | $ | 481 | | | $ | 975 | | | $ | — | | | $ | (123) | | | $ | 1,333 | |
(1)Netting adjustments represent the impact of counterparty and collateral netting on our derivative balances included on our Condensed Consolidated Statements of Financial Condition. See Note 5 for additional information. (2)Our available-for-sale securities primarily consist of agency MBS, agency CMOs, and U.S. Treasury securities (“U.S. Treasuries”). See Note 4 for further information. (3)These assets are primarily comprised of U.S. Treasuries purchased to meet certain deposit requirements with clearing organizations.
|
Level 3 Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis, Roll Forward Table of Change in Balances |
The following tables present the changes in fair value for Level 3 assets and liabilities measured at fair value on a recurring basis. The realized and unrealized gains and losses in the tables may include changes in fair value that were attributable to both observable and unobservable inputs. In the following tables, gains/(losses) on trading and derivative instruments are reported in “Principal transactions” and gains/(losses) on other investments are reported in “Other” revenues on our Condensed Consolidated Statements of Income and Comprehensive Income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, 2025 Level 3 instruments at fair value | | | Financial assets | | | | | | | | | Trading assets | | | | | Derivative assets | | Other investments | | | | | | | $ in millions | | Other | | | | | Other | | All other | | | | | | | Fair value beginning of period | | $ | 1 | | | | | | $ | 6 | | | $ | 7 | | | | | | | | Total gains/(losses) included in earnings | | 1 | | | | | | (5) | | | — | | | | | | | | Purchases and contributions | | 27 | | | | | | — | | | — | | | | | | | | Sales and distributions | | (27) | | | | | | — | | | — | | | | | | | | Transfers: | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | | | — | | | — | | | | | | | | Out of Level 3 | | — | | | | | | — | | | — | | | | | | | | Fair value end of period | | $ | 2 | | | | | | $ | 1 | | | $ | 7 | | | | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | | | $ | (5) | | | $ | — | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine months ended June 30, 2025 Level 3 instruments at fair value | | | Financial assets | | | | | | Trading assets | | | Derivative assets | | | | | Other investments | | | | | | | $ in millions | | Other | | | Other | | | | | All other | | | | | | | Fair value beginning of period | | $ | 3 | | | | $ | 4 | | | | | | $ | 7 | | | | | | | | Total gains/(losses) included in earnings | | 2 | | | | (3) | | | | | | — | | | | | | | | Purchases and contributions | | 66 | | | | — | | | | | | — | | | | | | | | Sales and distributions | | (69) | | | | — | | | | | | — | | | | | | | | Transfers: | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | — | | | | | | — | | | | | | | | Out of Level 3 | | — | | | | — | | | | | | — | | | | | | | | Fair value end of period | | $ | 2 | | | | $ | 1 | | | | | | $ | 7 | | | | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | — | | | | $ | (2) | | | | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, 2024 Level 3 instruments at fair value | | | Financial assets | | | | | | | | | | | | Trading assets | | | | | | | | Other investments | | | | | | | | | | $ in millions | | Other | | | | | | | | All other | | | | | | | | | | Fair value beginning of period | | $ | 4 | | | | | | | | | $ | 29 | | | | | | | | | | | Total gains/(losses) included in earnings | | — | | | | | | | | | — | | | | | | | | | | | Purchases and contributions | | 31 | | | | | | | | | — | | | | | | | | | | | Sales and distributions | | (22) | | | | | | | | | — | | | | | | | | | | | Transfers: | | | | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | | | | | | — | | | | | | | | | | | Out of Level 3 | | — | | | | | | | | | — | | | | | | | | | | | Fair value end of period | | $ | 13 | | | | | | | | | $ | 29 | | | | | | | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | (1) | | | | | | | | | $ | — | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Nine months ended June 30, 2024 Level 3 instruments at fair value | | | Financial assets | | | | | | | | | Trading assets | | | | | | | | Other investments | | | | | | | $ in millions | | Other | | | | | | | | All other | | | | | | | Fair value beginning of period | | $ | 4 | | | | | | | | | $ | 30 | | | | | | | | Total gains/(losses) included in earnings | | — | | | | | | | | | (1) | | | | | | | | Purchases and contributions | | 60 | | | | | | | | | — | | | | | | | | Sales and distributions | | (51) | | | | | | | | | — | | | | | | | | Transfers: | | | | | | | | | | | | | | | | | Into Level 3 | | — | | | | | | | | | — | | | | | | | | Out of Level 3 | | — | | | | | | | | | — | | | | | | | | Fair value end of period | | $ | 13 | | | | | | | | | $ | 29 | | | | | | | | Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | | $ | (1) | | | | | | | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | |
|
Net Asset Value of Recorded Value and Unfunded Commitments |
The following table presents the recorded value and unfunded commitments related to our private equity investments portfolio. | | | | | | | | | | | | | | | $ in millions | | Recorded value | | Unfunded commitment | June 30, 2025 | | | | | Private equity investments measured at NAV | | $ | 110 | | | $ | 31 | | Private equity investments not measured at NAV | | 7 | | | | Total private equity investments | | $ | 117 | | | | | | | | | September 30, 2024 | | | | | Private equity investments measured at NAV | | $ | 102 | | | $ | 26 | | Private equity investments not measured at NAV | | 7 | | | | Total private equity investments | | $ | 109 | | | |
|
Fair Value Measurements, Nonrecurring |
The following table presents assets measured at fair value on a nonrecurring basis along with the valuation techniques and significant unobservable inputs used in the valuation of the assets classified as level 3. These inputs represent those that a market participant would take into account when pricing these instruments. Weighted averages are calculated by weighting each input by the relative fair value of the related financial instrument. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | | | Level 2 | | Level 3 | | Total fair value | | Valuation technique(s) | | Unobservable input | | Range (weighted-average) | June 30, 2025 | | | | | | | | | | | | | | | Bank loans: | | | | | | | | | | | | | | | Residential mortgage loans | | | | $ | 2 | | | $ | 7 | | | $ | 9 | | | Collateral or discounted cash flow (1) | | Prepayment rate | | 7 yrs. - 12 yrs. (10.5 yrs.) | Corporate loans | | | | $ | — | | | $ | 132 | | | $ | 132 | | | Collateral or discounted cash flow (1) | | Recovery rate | | 35% - 35% (35%) | Loans held for sale | | | | $ | 38 | | | $ | — | | | $ | 38 | | | N/A (2) | | N/A | | N/A | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2024 | | | | | | | | | | | | | | | Bank loans: | | | | | | | | | | | | | | | Residential mortgage loans | | | | $ | 2 | | | $ | 7 | | | $ | 9 | | | Collateral or discounted cash flow (1) | | Prepayment rate | | 7 yrs. - 12 yrs. (10.5 yrs.) | Corporate loans | | | | $ | — | | | $ | 106 | | | $ | 106 | | | Collateral or discounted cash flow (1) | | Recovery rate | | 0% - 37% (37%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)The valuation techniques used to estimate the fair values are based on collateral value less selling costs for the collateral-dependent loans and discounted cash flows for loans that are not collateral-dependent. Unobservable inputs used in the collateral valuation technique are not meaningful and unobservable inputs used in the discounted cash flow valuation technique are presented in the table. (2)See the “Bank loans, net - Loans held for sale” section of Note 2 of our 2024 Form 10-K for information on the valuation techniques used in the valuation of our loans held for sale measured at fair value on a nonrecurring basis.
|
Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value |
The following table presents the estimated fair value and fair value hierarchy of financial assets and liabilities that are not recorded at fair value on the Condensed Consolidated Statements of Financial Condition at June 30, 2025 and September 30, 2024. This table excludes financial instruments that are carried at amounts which approximate fair value. See Note 4 of our 2024 Form 10-K for a discussion of our financial instruments that are not recorded at fair value. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ in millions | | | | Level 2 | | Level 3 | | Total estimated fair value | | Carrying amount | June 30, 2025 | | | | | | | | | | | Financial assets: | | | | | | | | | | | Bank loans, net | | | | $ | 217 | | | $ | 48,906 | | | $ | 49,123 | | | $ | 49,661 | | Financial liabilities: | | | | | | | | | | | Bank deposits - certificates of deposit | | | | $ | 1,788 | | | $ | — | | | $ | 1,788 | | | $ | 1,785 | | Other borrowings - subordinated notes payable | | | | $ | 98 | | | $ | — | | | $ | 98 | | | $ | 99 | | Senior notes payable | | | | $ | 1,774 | | | $ | — | | | $ | 1,774 | | | $ | 2,040 | | | | | | | | | | | | | September 30, 2024 | | | | | | | | | | | Financial assets: | | | | | | | | | | | Bank loans, net | | | | $ | 183 | | | $ | 45,002 | | | $ | 45,185 | | | $ | 45,879 | | Financial liabilities: | | | | | | | | | | | Bank deposits - certificates of deposit | | | | $ | 2,623 | | | $ | — | | | $ | 2,623 | | | $ | 2,612 | | Other borrowings - subordinated notes payable | | | | $ | 97 | | | $ | — | | | $ | 97 | | | $ | 99 | | Senior notes payable | | | | $ | 1,874 | | | $ | — | | | $ | 1,874 | | | $ | 2,040 | |
|